Genital warts treatment market

Genital Warts Treatment Market, by Drug Type (Imiquimod, Podophyllin and Podofilox, Trichloroacetic Acid, Sinecatechins, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Request Free Sample

Jul 2021
CMI4534
149 Pages
Excel & Pdf
Pharmaceutical

Summary

Genital warts refer to sexually transmitted infection that are usually caused due to Human Papilloma Virus (HPV). HPV is also known to cause some types of cancer as well. However, the type of HPV that causes genital warts does not usually cause cancer. Moreover, sexually transmitted infections or STIs are infections that spread through vaginal, oral, or anal transmissions or through close sexual contact. However, many people infected with HPV never even develop genital warts. If warts do develop, they usually appear within few months of infection. But sometimes, the warts may appear years later.

Increasing prevalence of (HPV) infection, which is the reason for the development of genital warts, is expected to drive the growth of the global genital warts treatment market over the forecast period.

According to the World Health Organization (WHO): 2019, more than 1 million sexually transmitted infections (STIs) are acquired every day worldwide and more than 290 million women have a human papillomavirus (HPV) infection

The global genital warts treatment market is estimated to be valued at US$ 1,628.9 million in 2021 and is expected to exhibit a CAGR of 4.7% over the forecast period (2021-2028).

Figure 1. Global Genital Warts Treatment Market Share (%) in Terms of Value, By Region, 2021

Market players are indulged in launching new treatment platforms that are expected to increase the growth of the global genital warts treatment market over the forecast period.

For instance, in 2019, GenieMD, a global provider of telemedicine services, launched their telemedicine app iVisit that would allow patients to be diagnosed and treated for genital warts via virtual visit with the physician.

For instance, in August 2018, Oceanside Pharmaceuticals, a company which provides pharmaceutical services, launched an authorized generic version of Bausch Health’s Zyclara (imiquimod) 3.75% cream pump. Zyclara (imiquimod) 3.75% is indicated for the topical treatment of external genital and perianal warts/condyloma acuminata (EGW) in patients of age 12 years or older.

Genital Warts Treatment Market Report Coverage

Report Coverage	Details
Base Year:	2020	Market Size in 2021:	US$ 1,628.9 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2021 to 2028
Forecast Period 2021 to 2028 CAGR:	4.7%	2028 Value Projection:	US$ 2,253.6 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Drug Type: Imiquimod, Podophyllin and Podofilox, Trichloroacetic Acid, Sinecatechins, Others By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Companies covered:	Sanofi S.A., AbbVie Inc., Perrigo Company PLC, 3M, Lee's Pharmaceutical Holdings Ltd, Cassiopea, Glenmark Pharmaceuticals, Bausch Health, and Novartis International AG
Growth Drivers:	Increasing Research and Development Activities Increasing Prevalence of Sexually Transmitted Diseases (STDs) and Human Papilloma Virus (HPV) infection
Restraints & Challenges:	Low Diagnostic Rate Due to Lack of Awareness

Figure 2. Global Genital Warts Treatment Market Share (%), by Drug Type, 2021

Increasing research and development in order to develop treatment for genital warts is expected to increase the growth of the global genital warts treatment market over the forecast period.

For instance, University of Pretoria, South Africa, in collaboration with University of Stellenbosch, South Africa, are currently conducting clinical trials in order to study the effectiveness of human papilloma virus (HPV) vaccine against the occurrence of genital warts. The study was initiated in the year 2018 and is expected to be completed by 2023. Currently, the study is in the Phase III clinical trial.

Global Genital Warts Treatment Market Restraint

Even though the prevalence of warts is high among the global population, its diagnosis rate is still low. The low diagnostic rate of genital warts is due to the lack of awareness about the infection, which may hamper the genital warts treatment market growth. For instance, according to the Health Protection report in 2018, the rate of genital warts’ diagnosis in England among girls aged 15 to 17 years, who were attending sexual health services, decreased by 92%, as compared to that in 2014. Moreover, existing treatment procedures are often painful or invasive, and can have undesirable outcomes such as scarring or dyspigmentation that often requires repeat visits. This results in decrease in the diagnostic rate, which in turn, is likely to restrain the genital warts therapeutics market.

Furthermore, there are no specific treatments available for genital warts. The most commonly used treatments are cauterization and freezing. On the other hand, the topical skin medications that are usually prescribed for the treatment of warts are commonly prescribed for skin conditions and skin cancers as well.

According to the National Center for Biotechnology Information (NCBI) report in 2018, in most of the cases, the immune system clears the warts within a few months. But even if the warts go away, the HPV might still be active in the body. So the warts can come back after few months or years.

Key Players

Major players operating in the global genital warts treatment market include Sanofi S.A., AbbVie Inc., Perrigo Company PLC, 3M, Lee's Pharmaceutical Holdings Ltd, Cassiopea, Glenmark Pharmaceuticals, Bausch Health, and Novartis International AG

Table of Content

Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

Market Purview

Report Description

Market Definition and Scope

Executive Summary

Market Snippet, By Drug Type
Market Snippet, By Distribution Channel
Market Snippet, By Region

Coherent Opportunity Map (COM)

Market Dynamics, Regulations, and Trends Analysis

Drivers
Restraints
Opportunity
Impact Analysis
Epidemiology
Mergers and Acquisitions
Key Developments
Regulatory Scenario
PEST Analysis
Reimbursement Scenario
Brand Analysis
Pipeline Analysis
Therapeutics : Overview
Algorithm For Treatment Selection In Patients With Genital Warts

Global Genital Warts Treatment Market – Impact of Coronavirus (Covid-19) Pandemic

COVID-19 Epidemiology
Supply and Demand Analysis

Global Genital Warts Treatment Market, By Drug Type, 2021 – 2028, (US$ Mn)

Introduction

Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 – 2028
Segment Trends

Imiquimod

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)

Podophyllin and Podofilox

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)

Trichloroacetic Acid

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)

Anti-depressants

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)

Sinecatechins

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)

Others

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)

Global Genital Warts Treatment Market, By Distribution Channel, 2021 – 2028, (US$ Mn)

Introduction

Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 – 2028
Segment Trends

Hospital Pharmacies

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)

Retail Pharmacies

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)

Online Pharmacies

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)

Global Genital Warts Treatment Market, By Region, 2021 – 2028, (US$ Mn)

Introduction

Market Share Analysis, By Region, 2021 and 2028 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2028

North America

Market Size and Forecast, By Drug Type, 2021 – 2028, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2021 – 2028, (US$ Mn)
Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)

U.S.
Canada

Latin America

Market Size and Forecast, By Drug Type, 2021 – 2028, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2021 – 2028, (US$ Mn)
Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)

Brazil
Mexico
Argentina
Rest of Latin America

Europe

Market Size and Forecast, By Drug Type, 2021 – 2028, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2021 – 2028, (US$ Mn)
Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific

Market Size and Forecast, By Drug Type, 2021 – 2028, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2021 – 2028, (US$ Mn)
Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East

Market Size and Forecast, By Drug Type, 2021 – 2028, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2021 – 2028, (US$ Mn)
Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)

GCC
Israel
Rest of Middle East

Africa

Market Size and Forecast, By Region/Country, 2021 – 2028, (US$ Mn)

South Africa
Central Africa
North Africa

Competitive Landscape

Competitive Snapshot

Sanofi S.A.*

- - - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - AbbVie Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Perrigo Company PLC
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - 3M
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Lee's Pharmaceutical Holdings Ltd
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Cassiopea
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Glenmark Pharmaceuticals
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Bausch Health
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Novartis International AG
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
Section

References
Research Methodology
About us and Sales Contact

*Browse 26 market data tables and 28 figures on "Genital Warts Treatment Market” - Global forecast to 2028

N/A

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the market during the forecast period (2021-2028)?

The market size is estimated to be valued at US$ 1,628.9 million in 2021 and is expected to exhibit a CAGR of 4.7% between 2021 and 2028.

What are the major factors driving the market growth?

Increasing research and development activities and increasing prevalence of sexually transmitted diseases (STDS) & human papilloma virus (HPV) infection are expected to drive the market growth over the forecast period.

Which is the leading drug type segment in the market?

Imiquimod drug type segment is expected to hold the major market share, owing to increasing product approvals and launches during the forecast period.

Which region holds the largest market share in the market?

North America holds the largest market share in the market.

What are the key factors hampering growth of the market?

Major factor hampering growth of the market includes the low diagnostic rate of genital rates due to lack of awareness.

Which are the major players operating in the market?

Major players operating in the market include Sanofi S.A., AbbVie Inc., Perrigo Company PLC, 3M, Lee's Pharmaceutical Holdings Ltd, Cassiopea, Glenmark Pharmaceuticals, Bausch Health, and Novartis International AG